Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
暂无分享,去创建一个
Josephine G. Walker | R. Garfein | J. Havens | M. Hellard | C. Aitken | F. Altice | S. Abbott | A. Trickey | J. Stone | Y. Sazonova | A. Lim | P. Vickerman | S. Strathdee | S. Hutchinson | M. Alary | M. Hickman | N. Martin | J. Bruneau | P. Dietze | R. Sacks-Davis | S. Mehta | M. Milloy | É. Roy | D. Abramovitz | L. Maher | N. Palmateer | V. Hope | V. Mravčík | T. Azim | A. Young | L. Platt | T. Tsertsvadze | M. Desai | A. McAuley | Zoe Ward | J. Iversen | G. Zang | P. Smyrnov | E. Heinsbroek | Hannah Fraser | M. Aladashvili | Louis MacGregor | Yung-Fen Yen | Malvina Aladashvili | Z. Ward
[1] J. Leung,et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review , 2017, The Lancet. Global health.
[2] H. Hagan,et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs , 2017, The Cochrane database of systematic reviews.
[3] J. Montaner,et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. , 2017, The lancet. HIV.
[4] A. Pharris,et al. Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens , 2017, The Journal of infectious diseases.
[5] P. Hayes,et al. Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland , 2017, Addiction.
[6] G. Lauer,et al. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] T. Vos,et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.
[8] Y. Kestens,et al. The role of living context in prescription opioid injection and the associated risk of hepatitis C infection. , 2016, Addiction.
[9] F. Altice,et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia , 2016, The Lancet.
[10] Reza Assadi,et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.
[11] B. Moazen,et al. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners , 2016, The Lancet.
[12] M. Mckee,et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees , 2016, The Lancet.
[13] P. Nguyen,et al. Impact of length of injecting career on HIV incidence among people who inject drugs. , 2016, Addictive behaviors.
[14] C. Beyrer,et al. Public health and international drug policy , 2016, The Lancet.
[15] Heino Stöver,et al. Prison-based needle and syringe programmes (PNSP) – Still highly controversial after all these years , 2016 .
[16] J. Montaner,et al. Sex work and HIV incidence among people who inject drugs , 2016, AIDS.
[17] M. Medina-Mora,et al. Risk of violence in drug rehabilitation centers: perceptions of people who inject drugs in Tijuana, Mexico , 2016, Substance Abuse Treatment, Prevention, and Policy.
[18] J. Montaner,et al. Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study. , 2015, The lancet. HIV.
[19] P. Nguyen,et al. Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users. , 2015, Addictive behaviors.
[20] D. Vlahov,et al. Incarceration and injection drug use in Baltimore, Maryland. , 2015, Addiction.
[21] C. Toro,et al. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes , 2015, Journal of Epidemiology & Community Health.
[22] Marie-Ève Turcotte,et al. P1254 : Hepatitis C spontaneous clearance may induce partial protection against reinfection among persons who inject drugs: Results from a cohort study , 2015 .
[23] M. Boily,et al. Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis. , 2015, Addiction.
[24] Elizabeth L. Ogburn,et al. High HIV burden among people who inject drugs in 15 Indian cities , 2015, AIDS.
[25] J. Hahn,et al. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. , 2014, JAMA internal medicine.
[26] F. Luciani,et al. A prospective study of hepatitis C incidence in Australian prisoners. , 2014, Addiction.
[27] V. Hope,et al. Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey , 2014, Epidemiology and Infection.
[28] S. Hutchinson,et al. Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions , 2014, PloS one.
[29] J. Mcnicholl,et al. Risk Behaviors and Risk Factors for HIV Infection among Participants in the Bangkok Tenofovir Study, an HIV Pre-Exposure Prophylaxis Trial among People Who Inject Drugs , 2014, PloS one.
[30] J. Parry,et al. Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities. , 2014, The International journal on drug policy.
[31] M. Hellard,et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. , 2014, International journal of epidemiology.
[32] J. Kaldor,et al. Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction , 2014, AIDS.
[33] M. Hellard,et al. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. , 2014, The International journal on drug policy.
[34] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[35] J. Kaldor,et al. Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study. , 2013, American journal of public health.
[36] M. Hickman,et al. Low incidence of hepatitis C virus among prisoners in Scotland. , 2013, Addiction.
[37] C. Aitken,et al. Establishing the Melbourne injecting drug user cohort study (MIX): rationale, methods, and baseline and twelve-month follow-up results , 2013, Harm Reduction Journal.
[38] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[39] Gail M. Williams,et al. Systematic review of record linkage studies of mortality in ex-prisoners: why (good) methods matter. , 2013, Addiction.
[40] J. Havens,et al. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. , 2013, American journal of public health.
[41] L. Topp,et al. Housing Instability among People Who Inject Drugs: Results from the Australian Needle and Syringe Program Survey , 2013, Journal of Urban Health.
[42] P Vickerman,et al. Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK. , 2012, Drug and alcohol dependence.
[43] R. Garfein,et al. HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007–2010 , 2012, The American journal of drug and alcohol abuse.
[44] P. Vickerman,et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[45] S. Hutchinson,et al. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. , 2012, The International journal on drug policy.
[46] M. Schechter,et al. The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities , 2012, BMC Public Health.
[47] J. Bruneau,et al. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. , 2012, Addiction.
[48] J. Steiner,et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors , 2012, Addiction Science & Clinical Practice.
[49] L. Møller,et al. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. , 2012, Addiction.
[50] Barbara Toson,et al. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration. , 2012, Addiction.
[51] A. Widell,et al. Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program , 2011, Journal of viral hepatitis.
[52] J. Parry,et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. , 2011, Addiction.
[53] M. Alary,et al. Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada , 2011, AIDS.
[54] M. Abrahamowicz,et al. Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study. , 2011, American journal of epidemiology.
[55] J. Parry,et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots , 2011, Journal of viral hepatitis.
[56] D. Vlahov,et al. Changes in blood-borne infection risk among injection drug users. , 2011, The Journal of infectious diseases.
[57] M. Farrell,et al. Meta-analysis of drug-related deaths soon after release from prison , 2010, Addiction.
[58] J. Tappero,et al. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003. , 2010, The International journal on drug policy.
[59] H. Hagan,et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. , 2010, The Journal of infectious diseases.
[60] J. Parry,et al. Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size , 2009, Epidemiology and Infection.
[61] J. Tappero,et al. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003. , 2009, Addiction.
[62] J. Montaner,et al. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors. , 2009, Drug and alcohol dependence.
[63] Margaret Hellard,et al. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users , 2008, Hepatology.
[64] M. Faruque,et al. Prevalence of Infections, HIV Risk Behaviors and Factors Associated with HIV Infection Among Male Injecting Drug Users Attending a Needle/Syringe Exchange Program in Dhaka, Bangladesh , 2008, Substance use & misuse.
[65] Kimberly C. Brouwer,et al. Individual, Social, and Environmental Influences Associated With HIV Infection Among Injection Drug Users in Tijuana, Mexico , 2008, Journal of acquired immune deficiency syndromes.
[66] K. Nelson,et al. Not All Injection Drug Users Are Created Equal: Heterogeneity of HIV, Hepatitis C Virus, and Hepatitis B Virus Infection in Georgia , 2008, Substance use & misuse.
[67] J. Kaldor,et al. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users , 2007, Journal of viral hepatitis.
[68] D. Vlahov,et al. HIV Incidence Among Injection Drug Users in Baltimore, Maryland (1988-2004) , 2006, Journal of acquired immune deficiency syndromes.
[69] Tania B. Huedo-Medina,et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? , 2006, Psychological methods.
[70] J. Montaner,et al. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study , 2006, Harm reduction journal.
[71] C. del Rio,et al. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. , 2006, Drug and alcohol dependence.
[72] C. Boileau,et al. A Prognostic Model for HIV Seroconversion Among Injection Drug Users as a Tool for Stratification in Clinical Trials , 2005, Journal of acquired immune deficiency syndromes.
[73] J. Montaner,et al. Recent Incarceration Independently Associated with Syringe Sharing by Injection Drug Users , 2005, Public health reports.
[74] J. Desenclos,et al. Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France , 2004, Epidemiology and Infection.
[75] J. Tappero,et al. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. , 2003, AIDS research and human retroviruses.
[76] M. Schechter,et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic , 2003, AIDS.
[77] J. Barry,et al. Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin , 2003, Journal of epidemiology and community health.
[78] R. Hogg,et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[79] M. Busch,et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.
[80] D. Vlahov,et al. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. , 2002, American journal of epidemiology.
[81] M. Schechter,et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[82] M. Hudgens,et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. , 2002, American journal of epidemiology.
[83] D. D. Des Jarlais,et al. Incarceration and Risk for HIV Infection Among Injection Drug Users in Bangkok , 2002, Journal of acquired immune deficiency syndromes.
[84] M. Schechter,et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection , 2022 .
[85] D. Vlahov,et al. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. , 2001, Archives of internal medicine.
[86] J. Esparza,et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand , 2001, AIDS.
[87] D. Harte,et al. Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users. , 2000, The New Zealand medical journal.
[88] J. Zhang,et al. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.
[89] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[90] M. Anglin,et al. HIV incidence among injection drug users. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.